Active factor (INN – International Non-proprietary Name)



Code ATC: С01ЕВ


Pharmacotherapeutic group

Drugs stimulating metabolic processes


Pharmacological properties

Riboxin belongs to group of anabolic drugs that stimulate the metabolic processes. Derivative (nucleoside) of purine, a precursor of adenosine triphosphate (ATP).


Indications for use

Combined treatment of myocardial infarction, coronary heart disease, cardiac arrhythmia, resulting from taking cardiac glycosides, myocardiodystrophy after infectious diseases. It is also recommended in cases of liver diseases (hepatitides, cirrhosis, hepatic steatosis), treatment of porphyria cutanea tarda. In addition, riboxin is used in surgeries on isolated kidney as agent of pharmacological protection, when blood flow of operated organ is temporarily off.


Pharmaceutical form

2% solution for injection in ampoules of 5 ml and 10 ml.



Local anaesthetic drugs
Nootropic drugs
Antihypertensive drugs
Drugs for a parenteral food
Medicines applied at poisonings and intoxications
Medicines for metabolic processes correction
Medicines for peripheric blood circulation
Mineral drugs, microcells
Salt solutions
Analgesic and antispasmodic drugs
Nonsteroidal anti-inflammatory drugs